HTVN 702: Vaccine Candidate

Step Forward Vaccine candidates like HTVN 702 are needed to build momentum by Jeannie Wraight If current HIV diagnoses rates persist, about 1 in 2 black men...

Targeting HIV Reservoirs

Hiding Place One focus of the amfAR 2016 CURE Summit targeted HIV reservoirs by Jeannie Wraight This year, amfAR marked World AIDS Day with the 2016 HIV...

Interferon & HIV

Luis J. Montaner DVM, D.Phil, of the Wistar Institute in Philadelphia, Pennsylvania has been studying the effects of interferon on HIV DNA and its...

Checking the Map

LifeGuide Destination: Cure Checking the Map Where are we on the road to a cure? by Jeannie Wraight The past year has been wrought with disappointment on the HIV...

Why We Need a Vaccine

As with any viral outbreak, the two main goals from Day One of the known HIV epidemic/pandemic have been controlling the spread of the...

Cure Research Setback?

Shock and Kill Research unveils new info about latent HIV reservoirs, signaling a possible cure setback by Jeannie Wraight Amid several recent successes in the pursuit for...

Counting Cures

Destination: Cure by Jeannie Wraight Counting Cures Before we start tallying “cures,” let’s strive to define what we mean by “cured?” Several months ago a media frenzy...

Expediting Research

GlaxoSmithKline (GSK) and the University of North Carolina at Chapel-Hill (UNC) will launch a jointly owned novel HIV Cure Center, as well as a...

Imbokodo Study Launches

The Strength of Women The Imbokodo Study launches in Southern Africa by Jeannie Wraight In Zulu, the word “Imbokodo” means “rock” and is part of a well-known...

David Evans

Risk & Reward Activist David Evans weighs in on next steps in cure advocacy & research by Jeannie Wraight In the late 1980s and throughout the ’90s,...

LATEST POSTS

Let’s Talk About PrEP

On July 27, 2018, Chicago’s Howard Brown Health unveiled a new song and music video, “Let’s Talk About PrEP,” intended to spread awareness about...